CrystalsFirst GmbH

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Insilico Medicine

This company develops artificial intelligence platforms for drug discovery and design to serve pharmaceutical and biotechnology organisations.

Deep MedChem

This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.

Inductive Bio

This company provides a machine learning platform for compound optimization and ADMET prediction to biopharma and drug discovery organisations.

CryoCloud

This company develops a cloud-based data analysis platform for cryo-electron microscopy to assist biotechnology, pharmaceutical and academic researchers with protein structure determination.

Aqemia

This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.

Single Cell Discoveries

This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.

Valence Discovery

This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.